Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
07-2015 | 04-2015 | 01-2015 | 10-2014 | 07-2014 | |
Sales | 95 | 25 | 9,135 | 1,375 | 1,187 |
Gross Profit | 95 | 25 | 9,135 | 1,375 | 1,187 |
Operating Expenses | 1,586 | 2,158 | 5,278 | 2,940 | 1,347 |
Operating Income | -1,491 | -2,133 | 3,857 | -1,565 | -160 |
Interest Expense | 116 | 109 | 109 | 182 | 281 |
Other Income | 5 | 5 | 5 | -1,407 | 852 |
Pre-tax Income | -1,602 | -2,237 | 3,752 | -3,153 | 411 |
Net Income Continuous | -1,602 | -2,237 | 3,752 | -3,153 | 411 |
Net Income | $-1,602 | $-2,237 | $3,752 | $-3,153 | $411 |
EPS Basic Total Ops | -0.18 | -0.26 | 0.43 | -0.15 | 0.05 |
EPS Basic Continuous Ops | -0.18 | -0.26 | 0.43 | -0.34 | 0.05 |
EPS Diluted Total Ops | -0.18 | -0.26 | 0.41 | -0.14 | 0.04 |
EPS Diluted Continuous Ops | -0.18 | -0.26 | 0.41 | -0.33 | 0.04 |
EBITDA(a) | $-1,293 | $-1,944 | $4,048 | $-1,324 | $150 |